Continuous bed motion versus step-and-shoot acquisition in LAFOV PET/CT: insights from multi-phantom and patient studies P. M. Linder, W. Lan, E. Calderón, I. Rausch, C. la Fougère, F. P. Schmidt Ejnmmi Physics, 2026 Background Continuous bed motion (CBM) allows flexible extension of the scan range compared to conventional step‑and‑shoot (S&S) acquisition but has not yet been evaluated in long axial field‑of‑view (LAFOV) PET/CT. This study systematically assessed the impact of CBM on image quality, noise, and quantitative performance in the Biograph Vision Quadra LAFOV PET/CT using multi‑phantom and patient scans compared to S&S. Methods A uniform tube phantom and a NEMA IEC phantom, positioned centrally and off-centre, were scanned across bed speeds (2.8–50 mm/s), sensitivity modes and scan ranges (106 and 150 cm) to evaluate image uniformity, axial count profiles, noise and contrast recovery coefficients (CRC). Ten oncological patients receiving [ 18 F]PSMA-1007 or [ 18 F]FDG underwent sequential CBM (2.8 mm/s, 378 s) and S&S (300 s) scans. Image noise, net true counts, and liver and lesion SUV values were compared using paired statistics and Bland–Altman analysis, along with PSMA expression scores. Results For comparable count statistics and image noise, CBM required a prolonged acquisition (378 s) to match the S&S (300 s) protocol, resulting in comparable image quality for phantoms and patients. CRC and image uniformity were preserved across all evaluated conditions, even at the FOV’s axial edge (50.5 cm) for 8.4 mm/s (22 mm sphere: CRC 76% S&S vs. 71% CBM). In patient scans, minor differences in axial count profiles, net true counts, and SUV values (SUV mean bias − 0.1 (liver) and − 0.8 (lesions)) did not affect clinical scores. Conclusions The prolonged CBM protocol provides image quality and quantitative performance comparable to S&S in LAFOV PET/CT. While the reconstructed image range remains constrained by CT coverage, the patient scan comparison with 106 cm scan range, together with extended range phantom measurements, indicate that CBM can support scan range extension beyond 106 cm without compromising diagnostic accuracy.
Estimation of Future Patient Populations Eligible for Radioligand Therapies in the EU and the UK: A Modelling Study Uwe Holzwarth, Roberta Cirillo, Margarida Goulart, Diego Hernandez, Platon Peristeris, Andreas Poschenrieder, Panagiota Papaioannou, Panos Kanavos, Christian la Fougère, Leonhard Schaetz Lancet Regional Health Europe, 2026 Background The eligible patient population for radioligand therapies (RLTs) has the potential to grow rapidly in the coming years. European healthcare systems may be ill-prepared to provide the additional treatment capacity required on top of current workload. To address this challenge, data on the size of the eligible patient pool and the potential utilisation of RLTs are needed. Methods The maximum pool of patients theoretically eligible for RLTs over the next decade was estimated for the 27 EU member states (EU-27) using incidence data, and additionally for France, Germany, Italy, Spain (EU-4) and the UK using prevalence data. Conditions for which RLT are currently authorised, potential expansions of existing authorisations to earlier disease stages, and anticipated authorisations for products in development were analysed. Findings Between 2025 and 2035 in the EU-27, the patient pool theoretically eligible for RLTs could increase from 11,000 to 13,000 to approximately 130,000–180,000. A scenario based on preliminary utilisation data suggests that, in the EU-4, 17,000–35,000 patients from this pool could be treated in 2030, increasing to approximately 37,000 patients by 2035. Interpretation The expected uptake of RLTs in EU healthcare systems over the coming decade may overwhelm available treatment capacity, even in countries with well-developed nuclear medicine infrastructure. Efforts across all EU countries will be required to ensure adequate patient access to RLTs and to minimise health inequalities in cancer care. Funding Research by WifOR was funded by Novartis Pharma AG. JRC research was covered by the European Commission's Research Framework Programmes budget.
Exploring extended [18F]FDG kinetics in lymphoma with ultra-late LAFOV-PET/CT Matthias Weissinger, Stephan Ursprung, Johann Jacoby, Jonas Vogel, Eduardo Calderón, Brigitte Gückel, Fabian Schmidt, Johannes Schwenck, Helmut Dittmann, Konstantin Nikolaou, Christian la Fougère, Christian Philipp Reinert European Journal of Nuclear Medicine and Molecular Imaging, 2026 Purpose This prospective trial investigated extended [¹⁸F]FDG kinetics in lymphoma to provide in-vivo insights into glucose metabolism with potential relevance for staging and risk stratification. Methods Fifteen consecutive, treatment- naïve lymphoma patients (4 Hodgkin, 11 non-Hodgkin) underwent routine whole-body [ 18 F]FDG-PET/CT at 1 h post injection (p.i., injected activity 3.02 ± 0.34 MBq/kg) followed by additional Long Axial Field-Of-View (LAFOV)-PET/CT scans at 3 h and 6 h p.i. (Biograph Vision Quadra ® , Siemens Healthineers; acquisition 5/15/30 min). Standardised uptake values (SUV) of lymphoma, benign lymph nodes, organs and reference tissues were quantified and multi time-point kinetics were described using Retention Indices (RI) and linear/quadratic trajectory analyses. Image quality was rated by two blinded readers on a 5-point Likert scale. Results Image quality remained diagnostic in all datasets. Median Tumour-to-Background Ratio (TBR) increased significantly from 4.1 (1 h p.i.) to 12.5 (3 h p.i.) and 23.9 (6 h p.i.), p < 0.001. High-grade lymphoma exhibited an almost linear SUV rise, whereas low-grade entities followed a parabolic course, peaking at 3 h p.i. Benign lymph nodes demonstrated constant uptake (1 h: 0.9 ± 0.3, 3 h: 0.8 ± 0.5, 6 h: 0.8 ± 0.4). RIs showed a significant increase in [¹⁸F]FDG uptake over time in lymphoma, compared with a decline in benign lymph nodes (1–3 h p.i.: 19.4% vs. -14.4%, p < 0.001). Conclusion The LAFOV scanner enables high-quality [¹⁸F]FDG PET imaging for up to 6 h p.i., with a six-fold increase of TBR in ultra-late scans 6 h p.i. Extended [¹⁸F]FDG kinetic analysis differentiates high- and low-grade lymphomas from benign lymph nodes and reveals a significant decline in tracer uptake low-grade lymphomas between 3 and 6 h p.i. Trial registration DRKS00027307. Registered 26 November 2021.
Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 30 Henryk Barthel, Matthias Brendel, Nathalie Albert, Henning Boecker, Caroline Bouter, Joachim Brumberg, Ralph Buchert, Christian La Fougère, Gerhard Gründer, Swen Hesse, Torsten Kuwert, Catharina Lange, Karl J. Langen, Philipp Lohmann, Philipp T. Meyer, Isabelle Miederer, Bernd Neumaier, Axel Rominger, Mathias Schreckenberger, Jörg B. Schulz, Igor Yakushev, Alexander Drzezga Nuklearmedizin Nuclearmedicine, 2026 Preamble This represents a substantial development of the guideline on the topic first published in 2016. The following notable points have been updated: the sections on background information; the clinical benefit of the method; the resulting differential diagnostic considerations; the outlook for possible future extensions of the indication spectrum; the quantitative analysis of the PET images; the embedding of the method in diagnostic pathways; and the relation to alternative biomarker methods such as amyloid measurement in CSF/blood.
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association study Maulikkumar Patel, Wei Feng, Nicole S Mckay, Peter R Millar, Menghan Liu, Chengran Yang, Arda Cetin, Matthew Johnson, John Budde, Daniel Western, Thomas W Marsh, Ibrahim O Saliu, Brian A Gordon, Jorge J Llibre Guerra, John C Morris, Randall J Bateman, Eric McDade, David M Holtzman, Natalie S Ryan, Tammie L S Benzinger, Alan E Renton, Alison M Goate, Laura Ibanez, Yun Ju Sung, Guoyan Zhao, Carlos Cruchaga, Cyril Pottier, Randall Bateman, Alisha J. Daniels, Laura Courtney, Angela Ziegemeier, Karina Skrbec, Cortaiga Hellm, Mariana Martin, Ellen Ziegemeier, Jamie Bartzel, Eric McDade, Jorge J. Llibre-Guerra, Charlene Supnet-Bell, Chengie Xiong, Xiong Xu, Ruijin Lu, Guoqiao Wang, Yan Li, Yuzheng Nie, Emily Gremminger, Richard J. Perrin, Erin Franklin, Laura Ibanez, Gina Jerome, Jennifer Stauber, Bryce Baker, Matthew Minton, Carlos Cruchaga, Alison M. Goate, Alan E. Renton, Danielle M. Picarello, Brian Fulton-Howard, Tammie L.S. Benzinger, Brian A. Gordon, Jessica Banks, Russ Hornbeck, Allison Chen, Charles Chen, Shaney Flores, Manu Goyal, Diana Hobbs, Nelly Joseph-Mathurin, Kelley Jackson, Sarah Keefe, Deborah Koudelis, Parinaz Massoumzadeh, Austin McCullough, Nicole McKay, Joyce Nicklaus, Christine Pulizos, Qing Wang, Edita Sabaredzovic, Jalen Scott, Ashlee Simmons, Jacqueline Rizzo, Andrei Vlassenko, Yong Wang, Jason Hassenstab, Jennifer Smith, Sarah Stout, Andrew J. Aschenbrenner, Celeste M. Karch, Jacob Marsh, John C. Morris, David M. Holtzman, Nicolas R. Barthélemy, Jinbin Xu, Sarah B. Berman, Snezana Ikonomovic, Gregory S. Day, Neill R. Graff-Radford, Martin Farlow, Jasmeer P. Chhatwal, Courtney Maa, Takeshi Ikeuchi, Kensaku Kasuga, Takanobu Ishiguro, Kenji Ishii, Michio Senda, Yoshiki Niimi, Edward D. Huey, Stephen Salloway, Emma Devenney, Peter R. Schofield, William S. Brooks, Jacob A. Bechara, Ralph Martins, Nick C. Fox, David M. Cash, Natalie S. Ryan, Mathias Jucker, Christoph Laske, Reda Timofejavaite, Elke Kuder-Buletta, Susanne Graber-Sultan, Christian la Fougère, Gerald Reischl, Ulrike Obermueller, Johannes Levin, Yvonne Rödenbeck, Jonathan Vöglein, Jae-Hong Lee, Jee Hoon Roh, Pedro Rosa-Neto, Ricardo F. Allegri, Patricio Chrem Mendez, Ezequiel Surace, Silvia Vazquez, David Aguillon, Yudy Milena Leon, Laura Ramirez, Laura Serna, Ana Baena, Yamile Bocanegra, Allan I. Levey, Erik C.B Johnson, Nicholas T. Seyfried, John Ringman, Anne M. Fagan, Hiroshi Mori, Colin Masters, James M. Noble, Raquel Sanchez-Valle, Francisco Lopera Lancet Neurology, 2026 BACKGROUND: Individuals with autosomal dominant Alzheimer's disease (ADAD) arising from mutations in PSEN1, PSEN2, or APP exhibit variability in clinical presentation. Genetic studies of ADAD have shaped our understanding of the disease, and the discovery of genetic modifiers can inform therapeutic interventions and improve patient outcomes. We aimed to discover new genetic modifiers in individuals with mutations in the three ADAD genes. METHODS: In this genome-wide association study, we analysed data from participants in three study cohorts (the Knight Alzheimer Disease Research Center [Knight-ADRC], the Dominantly Inherited Alzheimer Network [DIAN] observational study, and the Alzheimer Disease Sequencing Project [ADSP] R4). We did whole-genome sequencing on 101 unrelated, non-Hispanic, White, symptomatic participants with ADAD mutations and 5050 asymptomatic, unrelated control participants. Sensitivity analyses included related participants (148 cases and 5813 controls). We assessed the molecular mechanisms associated with each risk variant, including cis-regulatory effects, plasma protein levels (Knight-ADRC, 2338 participants), CSF concentrations of Alzheimer's disease biomarkers (DIAN, 64 participants), and neuroimaging data (MRI and PET; DIAN, 64 participants). We evaluated the association of risk variants with age at onset in ADAD and in 6177 participants with sporadic Alzheimer's disease (ADSP R5). FINDINGS: Three genome-wide loci with significant risk were associated with ADAD risk, irrespective of the specific ADAD gene mutation. The CNIH4 locus association was driven by a missense variant (is caused by Gly54Ser, p<0·0001, odds ratio [OR] 11·99 [5·39-26·64]). The CCNG1 locus risk allele increased the risk of Alzheimer's disease (p<0·0001, OR 9·56 [4·29-21·24]) and reduced the age at dementia onset (p=0·0068, β=-10·15 [95% CI -17·31 to -2·77]). This allele was also positively associated with Tar DNA binding protein 43 (TDP-43) plasma protein levels and a larger gap between chronological age and structural MRI predicted brain age. The RHOJ risk allele (p<0·0001, OR 5·96 [3·42-10·36]) was associated with increased the risk of Alzheimer's disease, higher CSF total tau (p=0·0056, β=358·37) and phosphorated tau 181 (pTau181; p=0·0006, β=81·28), and lower Aβ42/Aβ40 ratio (p=0·016, β=-0·11) in DIAN ADAD participants, comparing those carrying the risk allele with those not carrying it. INTERPRETATION: Our findings provide potential insights into disease biology, emphasising the role of Aβ, tau, TDP-43, astrocytes, and angiogenesis in Alzheimer's disease aetiology. This study offers invaluable insight for family genetic counselling and future clinical trial designs. FUNDING: National Institute of Health, National Institute on Aging, Alzheimer's Association, Hope Center Pilot 2025 Award, NGI Pilot Grant 2025 Award, BrightFocus Foundation, UK Dementia Research Institute at University College London, UK National Institutes for Health and Care Research University College London Hospitals Biomedical Research Centre, Dominantly Inherited Alzheimer Network, Freedom Together Foundation.
The PET tracer [¹¹C]MODAG-005 targets alpha-synuclein aggregates in the brain Ran Sing Saw, Sabrina Haas, Felix Schmidt, Sergey Ryazanov, Andrei Leonov, Daniel Bleher, Ann-Kathrin Grotegerd, Laura Kuebler, Benjamin Roeben, Fabian Schmidt, Matthias Reimold, Federica Bonanno, Viktoria C. Ruf, Bernadette Dahl, Christine M. Sandiego, Kelly E. Henry, Ioannis Papadopoulos, Martin Schaller, Philipp J. Kahle, Johannes Levin, Thomas Gasser, Kathrin Brockmann, Gerald Reischl, Christian la Fougère, Bernd J. Pichler, Andreas Maurer, Christian Griesinger, Armin Giese, Kristina Herfert Science Translational Medicine, 2026 Synucleinopathies are neurodegenerative diseases characterized by the presence of brain inclusions containing the pathologically aggregated protein α-synuclein. The development of a positron emission tomography tracer to detect aggregates of misfolded α-synuclein could revolutionize early diagnosis, disease monitoring, and the evaluation of therapeutic efficacy. Here, we present the development, preclinical validation, and first-in-human evaluation of [ 11 C]MODAG-005. In vitro binding experiments demonstrated subnanomolar binding affinity to recombinant α-synuclein fibrils and to α-synuclein inclusions in human brain tissue. Specific binding in multiple system atrophy (MSA) brain tissue was detected using autoradiography and microautoradiography and was validated through immunostaining. In vivo, [ 11 C]MODAG-005 showed good brain penetration, rapid clearance from brain tissue, and low metabolite formation in rodents and nonhuman primates. In addition, a pronounced binding and a good signal-to-noise ratio were achieved in an α-synuclein fibril–injected rat model and in an α-synuclein (A30P) transgenic mouse model in correlation to the pathological load. To validate the potential of [ 11 C]MODAG-005 for therapeutic development, we showed target engagement of the drug candidate anle138b in the brain tissues from α-synuclein (A30P) mice and patients with multiple system atrophy as well as in vivo in α-synuclein fibril–injected rats. Last, first-in-human imaging demonstrated [ 11 C]MODAG-005 binding in brain regions affected by α-synuclein pathology in patients with clinically established MSA cerebellar type, MSA cerebellar and parkinsonian type, and Parkinson’s disease.
PET-imaging derived prognostic factors for prostate cancer patients with visceral metastases receiving [177Lu]Lu-PSMA radiopharmaceutical therapy (RPT) Magdalena Sophie Späth, Helmut Dittmann, Richard Spallek, Eduardo Calderón, Jonas Mück, Andreas Brendlin, Steffen Rausch, Christian la Fougère, Nils F. Trautwein European Journal of Nuclear Medicine and Molecular Imaging, 2026 Visceral metastases are a significant risk factor and may be the most critical determinant of outcome in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing [¹⁷⁷Lu]Lu-PSMA RPT. In this monocentric real-world study, we evaluated baseline parameters derived from PET scans prior to RPT in order to identify potential prognostic factors in mCRPC patients with visceral metastases. This retrospective study included 320 men with mCRPC treated with in total 1077 cycles of [ 177 Lu]Lu-PSMA RPT (1–12 cycles/patient). Baseline characteristics, including age, PSA level, Gleason score, metastatic sites, and prior treatments, were evaluated as potential prognostic factors in the overall cohort. 65 patients were diagnosed with visceral metastases. In this subgroup, we analyzed the PET-derived parameters whole body PSMA-positive tumor volume (PSMA-TV), SUVmax, SUVmean, miPSMA expression score and the metastatic pattern of visceral metastases. The estimated median overall survival (OS) for the entire cohort was 15 months. Presence of visceral metastases, Gleason score, and PSA level were significant negative prognostic baseline factors for the entire cohort in the multivariate Cox regression score. The estimated median OS for patients with visceral metastases was 10 months, which was significantly lower than the 16 months observed for patients without visceral metastases. PSMA-TV, miPSMA expression score, and the metastatic pattern were identified as independent prognostic factors in multivariate Cox regression analysis. Patients exhibiting two risk factors or more demonstrated a significantly poorer OS of 4 months compared to patients with a maximum of one risk factor, who showed an OS of 15 months. This study confirmed that visceral metastases represent a major risk factor in patients with mCRPC undergoing [ 177 Lu]Lu-PSMA RPT. Moreover, PSMA-PET-derived parameters assessed prior to RPT enabled the distinction between high-risk and low-risk subgroups among patients with visceral metastases. These prognostic factors may therefore contribute to improved therapy stratification in mCRPC patients with visceral metastases undergoing [ 177 Lu]Lu-PSMA RPT.
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management Frederik L. Giesel, Stefan A. Koerber, Boris Hadaschik, Selina Kiefer, Sarah Schwarzenboeck, Kambiz Rahbar, Thorsten Derlin, Christoph A. Grott, Matthias Heck, Cordula Jilg, Philipp T. Meyer, Juri Ruf, Karl Schmidt, Joerg Kotzerke, Christian la Fougère, Gerald Reischl, Irene Virgolini, Ken Herrmann, Irene A. Burger, Theo Lorenzini, Martin Werner, Albrecht Stenzinger, Kristina Schwamborn, Jan Philipp Radtke, Markus Hohenfellner, Juergen Debus, Wolfgang A. Weber, Uwe Haberkorn, Klaus Kopka, Matthias Eiber, , Ursula Sahm, Steffen Rausch, Clemens Decristofero, Christian Uprimny, Gianpaolo di Santo, Christine Rangger, Gerd Wunderlich, Johannes Huber, Ulrich Sommer, Anass Johayem, Philipp A. Kaufmann, Daniel Eberli, Eric Tonndorf-Martini, Mathias Muehlhauser, Clemens Kratochwil, Kai Schubert, Oliver Kiss, Ute Hennrich, Peter Choyke, Claus Zippel, Otmar Wiestler, Michael Baumann, Annette Reil-Held, Volker Meyer, Sandra Meese, Tobias Maurer, Marianne Remke, Petra Watzlowik, Franz Gildehaus, Olaf Prante, Alexander Höpping, Gesine Kabuss, Jürgen Gschwend, Gabriele Kienzle European Journal of Nuclear Medicine and Molecular Imaging, 2026 Purpose Clinically accurate detection of prostate cancer (PCa) metastases is crucial for management of high-risk PCa patients scheduled for radical prostatectomy. We determine the safety and diagnostic accuracy of pre-operative 68 Ga-PSMA-11 PET/CT imaging in newly diagnosed high-risk PCa and assess its impact on patient management. Methods Investigator-initiated prospective multi-center multinational single-arm open-label phase 1/2 imaging trial (EuRadCT 2016–001815-19). Patients with high-risk PCa scheduled for prostatectomy were enrolled at 9 institutions in Germany, Austria, and Switzerland to undergo 68 Ga-PSMA-11 PET/CT for primary staging. The primary objectives were the evaluation of 68 Ga-PSMA-11 PET/CT imaging to detect the primary tumor and lymph node disease and safety assessment. Secondary objectives included detection of distant metastases, correlation of 68 Ga-PSMA-11 uptake with Gleason Score, and determining the impact on clinical management. Impact of pre-operative 68 Ga-PSMA-11 PET/CT imaging on target volume definition for radiation therapy was assessed. Results 173 patients underwent 68 Ga-PSMA-11 PET/CT for primary staging. Histopathologic correlation was available in 139 patients (imaging dataset), with lymph node metastases in 55 patients (39.6%). 20 treatment-emergent AEs unrelated to the test item were reported in 14 of 173 (8.1%) patients and no SAE occurred. On a per-patient basis, sensitivity of 68 Ga-PSMA-11 PET for local disease was 0.971 (95% CI, 0.928–0.992). Sensitivity, specificity, PPV, NPV and accuracy to detect local lymph node disease on a per-patient basis were 0.400 (95% CI 0.271–0.529), 0.988 (95%CI 0.965–1.000), 0.957 (95% CI 0.873–1.000), 0.716 (95% CI 0.633–0.798) and 0.755 (95% CI 0.684–0.827), respectively. Considering the intrinsic PET resolution of 3–5 mm, the exclusion of lesions smaller than 3 or 5 mm on histopathology from the analysis led to increased sensitivity of 56.4% and 69.0%, respectively. Median SUVpeak of local disease was 6.4 (range 1.7–13.6), 8.4 (range 2.3–39.4), 10.7 (range 5.6–23.0), and 13.4 (range 3.8–56.9) for Gleason Score 7a, 7b, 8 and 9, respectively. Based on the results of 68 Ga-PSMA-11 PET/CT, surgical intervention was canceled in 23 patients (13.2%). 68 Ga-PSMA-11 PET/CT resulted in a change of target volume delineation for radiation therapy planning in 29 patients (20.9%). Conclusion In high-risk primary PCa, 68 Ga-PSMA-11 is safe and effective in local staging, resulting in changes in both surgical and radiation management. Moreover, 68 Ga-PSMA-11 uptake is positively correlated with tumor grade and its efficacy is dependent on the size of nodal lesions. 68 Ga-PSMA-11 PET/CT will be highly impactful in the management of newly diagnosed high risk prostate cancer patients. Funding The study was funded by the German Cancer Consortium (DKTK).
Longitudinal subcortical volume changes and their correlations with multiple PET and fluid biomarkers in dominantly inherited Alzheimer’s disease IL Han Choo, Hoyoung Park, Brian A. Gordon, Randall J. Bateman, Randall Bateman, Alisha J. Daniels, Laura Courtney, Angela Ziegemeier, Karina Skrbec, Cortaiga Hellm, Mariana Martin, Ellen Ziegemeier, Jamie Bartzel, Eric McDade, Jorge J. Libre-Guerra, Charlene Supnet-Bell, Chengie Xiong, Xiong Xu, Ruijin Lu, Guoqiao Wang, Yan Li, Yuzheng Nie, Emily Gremminger, Richard J. Perrin, Erin Franklin, Laura Ibanez, Gina Jerome, Jennifer Stauber, Bryce Baker, Matthew Minton, Carlos Cruchaga, Alison M. Goate, Alan E. Renton, Danielle M. Picarello, Brian Fulton-Howard, Tammie L.S. Benzinger, Brian A. Gordon, Jessica Banks, Russ Hornbeck, Allison Chen, Charles Chen, Shaney Flores, Manu Goyal, Diana Hobbs, Nelly Joseph-Mathurin, Kelley Jackson, Sarah Keefe, Deborah Koudelis, Parinaz Massoumzadeh, Austin McCullough, Nicole McKay, Joyce Nicklaus, Christine Pulizos, Qing Wang, Edita Sabaredzovic, Jalen Scott, Ashlee Simmons, Jacqueline Rizzo, Andrei Vlassenko, Yong Wang, Jason Hassenstab, Jennifer Smith, Sarah Stout, Andrew J. Aschenbrenner, Celeste M. Karch, Jacob Marsh, John C. Morris, David M. Holzman, Nicolas R. Barthélemy, Jinbin Xu, Sarah B. Berman, Snezana Ikonomovic, Gregory S. Day, Neill R. Graff-Radford, Marin Farlow, Jasmeer P. Chhatwal, Takeshi Ikeuchi, Kensaku Kasuga, Takanobu Ishiguro, Kenju Ishii, Michio Senda, Yoshiki Niimi, Edward D. Huey, Stephen Salloway, Emma Devenney, Peter R. Schofield, William S. Brooks, Jacob A. Bechara, Ralph Martins, Nick C. Fox, David M. Cash, Natalie S. Ryan, Mathias Jucker, Christoph Laske, Reda Timofejavaite, Elke Kuder-Buletta, Susanne Graber-Sultan, Christian la Fougère, Gerald Reischl, Ulrike Obermueller, Johannes Levin, Yvonne Rödenbeck, Jonathan Vöglein, Jae-Hong Lee, Jee Hoon Roh, Paolo Vitali, Ricardo F. Allegri, Patricio Chrem Mendez, Ezequiel Surace, Silvia Vazquez, David Aguillon, Yudy Milena Leon, Laura Ramirez, Laura Serna, Ana Baena, Yamile Bocanegra, Allan I. Levey, Erik C.B. Johnson, Nicholas T. Seyfried, John Ringman, Anne M. Fagan, Hiroshi Mori, Colin Masters, James M. Nobles, Raquel Sanchez-Valle, Francisco Lopera Journal of Prevention of Alzheimer S Disease, 2026 BACKGROUND: Alzheimer's disease postmortem studies demonstrate that amyloid plaques and neurofibrillary tangles are present in subcortical regions. OBJECTIVE: To investigate longitudinal subcortical structural changes in autosomal dominant Alzheimer's disease in relation to multiple PET and fluid biomarkers. DESIGN: Dominantly Inherited Alzheimer's Network (DIAN) Observational study SETTING: Multicenter study PARTICIPANTS: Participants were identified as mutation-carriers of pathologic variants in presenilin-1, presenilin-2, or amyloid precursor protein and as non-carriers from the same families as the mutation-carriers. They underwent baseline and 2 and more times longitudinal follow-up assessments of multiple biomarkers MEASUREMENTS: Participants underwent structural MRI, ¹¹C-Pittsburgh Compound B PET, ¹⁸F-fluorodeoxyglucose PET, and CSF and plasma assessments. Rates of biomarker change as a function of estimated years to symptom onset were estimated using multivariate linear mixed-effects models, and longitudinal associations between subcortical atrophy and multiple biomarkers were evaluated. RESULTS: A total of 601 participants completed one or more clinical evaluations, with up to eight annual visits. Mutation carriers showed significantly greater longitudinal atrophy in the left amygdala, bilateral thalamus, putamen, nucleus accumbens, and hippocampus compared with non-carriers (Bonferroni-corrected p < 0.05). The earliest divergence was observed 13.2 years before the expected symptom onset in the right nucleus accumbens, following amyloid-β (Aβ) accumulation in the right thalamus that began 23.8 years before onset. Among carriers, atrophy in the right thalamus, bilateral putamen, and bilateral nucleus accumbens was significantly associated with region-specific or cortical Aβ accumulation, as well as with CSF Aβ42, Aβ42/Aβ40 ratio, total tau, and phosphorylated tau (Bonferroni-corrected p < 0.05). CONCLUSIONS: The present findings may provide a unique and well-characterized model for investigating the temporal ordering of Alzheimer's disease biomarkers.
AutoPET Challenge on Fully Automated Lesion Segmentation in Oncologic PET/CT Imaging, Part 2: Domain Generalization Jakob Dexl, Sergios Gatidis, Marcel Früh, Katharina Jeblick, Andreas Mittermeier, Anna Theresa Stüber, Balthasar Schachtner, Johanna Topalis, Matthias P. Fabritius, Sijing Gu, Gowtham Krishnan Murugesan, Jeff VanOss, Jin Ye, Junjun He, Anissa Alloula, Bartłomiej W. Papież, Zacharia Mesbah, Romain Modzelewski, Matthias Hadlich, Zdravko Marinov, Rainer Stiefelhagen, Fabian Isensee, Klaus H. Maier-Hein, Adrian Galdran, Konstantin Nikolaou, Christian la Fougère, Moon Kim, Nico Kallenberg, Jens Kleesiek, Ken Herrmann, Rudolf Werner, Michael Ingrisch, Clemens C. Cyran, Thomas Küstner Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2026 The second autoPET challenge provides a comprehensive evaluation of the current state of automated PET/CT tumor segmentation, highlighting both progress and persistent challenges of single-source domain generalization and the need for diverse public datasets to enhance algorithm robustness.
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma Alexander P Landry, Justin Z Wang, Vikas Patil, Andrew Ajisebutu, Chloe Gui, Leeor S Yefet, Yosef Ellenbogen, Jeff Liu, Yasin Mamatjan, Qingxia Wei, Olivia Singh, Sheila Mansouri, Felix Ehret, David Capper, Aaron A Cohen-Gadol, Ghazaleh Tabatabai, Marcos Tatagiba, Felix Behling, Jill S Barnholtz-Sloan, Andrew E Sloan, Lola B Chambless, Alireza Mansouri, Serge Makarenko, Stephen Yip, Derek S Tsang, Andrew Gao, Kenneth Aldape, Farshad Nassiri, Gelareh Zadeh, , Thomas Santarius, Warren Selman, Marta Couce, Andrew E Sloan, Priscilla K Brastianos, Helen A Shih, W Linda Bi, Raymond Y Huang, Patrick Y Wen, Tobias Walbert, Ian Lee, Michelle Felicella, Chaya Brodie, Tathiane Malta, Ana Valeria C Castro, Houtan Noushmehr, James Snyder, Francesco Dimeco, Andrea Saladino, Bianca Pollo, Christian Schichor, Jorg-Christian Tonn, Timothy J Kaufmann, Daniel Lachance, Caterina Giannini, Evanthia Galanis, Aditya Raghunathan, C Oliver Hanemann, Karolyn Au, Roland Goldbrunner, Norbert Galldiks, Marco Timmer, Nils Ole Schimdt, Christel Herold-Mende, Felix Sahm, Christine Jungk, Gerhard Jungwirth, Andreas Von Deimling, Michael D Jenkinson, Christopher P Millward, Abdurrahman I Islim, Katharine Drummond, Andrew Morokoff, Ghazaleh Tabatabai, Felix Behling, Mirjam Renovanz, Marcos Tatagiba, Antonio Santacroce, Christian la Fougere, Jens Schittenhelm, David R Raleigh, Arie Perry, Nicholas Butowski, Manfred Westphal, Katrin Lamszus, Franz Ricklefs, Christian Mawrin, Craig M Horbinski, Ho-Keung Ng, Matija Snuderl, Sylvia Kurz, Erik P Sulman, Gabriel Zada, Aaron Cohen-Gadol, Stephen Yip, Serge Makarenko, Viktor Zherebitskiy, Luke Hnenny, Ian F Dunn, Jennifer Moliterno, Michael W McDermott, Michael Vogelbaum, Mohsen Javadpour, Daniel Fountain, Tiit Illimar Mathiesen, Kenneth Aldape, Jill Barnholtz-Sloan, Omar Pathmanaban, Paul C Boutros, Tzannis Alkividias, Konstantinos N Fountas, Kyle M Walsh, Susan C Short, Bruno Carvalho, Sybren L N Maas, Eelke M Bos, Alper Dincer, Sylvia Kurz, Peter Passlack, Maximilian Deng, Felix Ehret, Minesh P Mehta, Yazmin Odia, Richard Everson, James A Balogun, Clara Lopez, Evan Calabrese, Philipp Karschnia, Nico Teske, Laura Fariselli, Tobias Greve, Christina Arvaniti, Carolina Benjamin, Michael Ivan, Christina Jackson, Sanjeeva Jeyaretna, Daniele Scartoni, Dante Amelio, Joshua Palmer, Jana Ivanidze, Quinn Ostrom, Duong Trung Kien, Mark Youngblood, Miguel Millareschavez, Malak AlThgafi, Sam Emerson, Michael Weller, Emilie LeRhun, Rafael Martínez-Pérez, Robert Smee, Raj Mukherjee, Andres Cervio, Clinton Turner, Will Muirhead, Eric Suero Molina, Vitowanu Julius, Jiawei Chen, Brij Karmur, Maciej Mrugala, Brian Neth Neuro Oncology, 2026
Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's disease James T. Kennedy, Julie K. Wisch, Anna H. Boerwinkle, Peter R. Millar, Nicole S. McKay, Adam M. Brickman, Jasmeer P. Chhatwal, Patricio Chrem Mendez, Bradley T. Christian, Anne Cohen, Carlos Cruchaga, Alisha Daniels, Shaney Flores, Benjamin L. Handen, Sigan L. Hartley, Elizabeth Head, Laura Ibanez, Sharon J. Krisnsky‐McHale, Christian la Fougere, Florence Lai, Charles M. Laymon, Joseph H. Lee, Jae‐Hong Lee, Johannes Levin, Jorge Llibre‐Guerra, David F. Aguillon, Ira T. Lott, Mark Mapstone, Eric McDade, John Morris, Sid E. O'Bryant, Julie C. Price, Michael S. Rafii, Jee Hoon Roh, H. Diana Rosas, Nicole Schupf, Charlene Supnet‐Bell, Chengjie Xiong, Shahid Zaman, Tammie L. S. Benzinger, Brian A. Gordon, Beau M. Ances, and Alzheimer S and Dementia, 2026
Cortical asymmetry in autosomal dominant Alzheimer’s disease progression Agnès Pérez-Millan, Neus Falgàs, Beatriz Bosch, Sergi Borrego-Écija, Anna Antonell, Guadalupe Fernández-Villullas, Diana Esteller-Gauxax, Adrià Tort-Merino, Núria Bargalló, Mircea Balasa, Albert Lladó, David Aguillon, Patricio Chrem, Gregory S Day, Emma Devenney, Edward D Huey, Takeshi Ikeuchi, Mathias Jucker, Kensaku Kasuga, Jonathan Vöglein, Jee Hoon Roh, Paolo Vitali, Ana Luisa Sosa Ortiz, Jorge J Llibre-Guerra, Brian A Gordon, Eric McDade, Randall J Bateman, Raquel Sánchez-Valle, , Randall Bateman, Alisha J Daniels, Laura Courtney, Angela Ziegemeier, Karina Skrbec, Cortaiga Hellm, Mariana Martin, Ellen Ziegemeier, Jamie Bartzel, Eric McDade, Jorge J Llibre-Guerra, Charlene Supnet-Bell, Chengie Xiong, Xiong Xu, Ruijin Lu, Guoqiao Wang, Yan Li, Yuzheng Nie, Emily Gremminger, Richard J Perrin, Erin Franklin, Laura Ibanez, Gina Jerome, Jennifer Stauber, Bryce Baker, Matthew Minton, Carlos Cruchaga, Alison M Goate, Alan E Renton, Danielle M Picarello, Brian Fulton-Howard, Tammie L S Benzinger, Brian A Gordon, Jessica Banks, Russ Hornbeck, Allison Chen, Charles Chen, Shaney Flores, Manu Goyal, Diana Hobbs, Nelly Joseph-Mathurin, Kelley Jackson, Sarah Keefe, Deborah Koudelis, Parinaz Massoumzadeh, Austin McCullough, Nicole McKay, Joyce Nicklaus, Christine Pulizos, Qing Wang, Edita Sabaredzovic, Jalen Scott, Ashlee Simmons, Jacqueline Rizzo, Andrei Vlassenko, Yong Wang, Jason Hassenstab, Jennifer Smith, Sarah Stout, Andrew J Aschenbrenner, Celeste M Karch, Jacob Marsh, John C Morris, David M Holtzman, Nicolas R Barthélemy, Jinbin Xu, Sarah B Berman, Snezana Ikonomovic, Gregory S Day, Neill R Graff-Radford, Martin Farlow, Jasmeer P Chhatwal, Courtney Maa, Takeshi Ikeuchi, Kensaku Kasuga, Takanobu Ishiguro, Kenji Ishii, Michio Senda, Yoshiki Niimi, Edward D Huey, Stephen Salloway, Emma Devenney, Peter R Schofield, William S Brooks, Jacob A Bechara, Ralph Martins, Nick C Fox, David M Cash, Natalie S Ryan, Mathias Jucker, Christoph Laske, Reda Timofejavaite, Elke Kuder-Buletta, Susanne Graber-Sultan, Christian la Fougère, Gerald Reischl, Ulrike Obermueller, Johannes Levin, Yvonne Rödenbeck, Jonathan Vöglein, Jae-Hong Lee, Jee Hoon Roh, Paolo Vitali, Ricardo F Allegri, Patricio Chrem Mendez, Ezequiel Surace, Silvia Vazquez, David Aguillon, Yudy Milena Leon, Laura Ramirez, Laura Serna, Ana Baena, Yamile Bocanegra, Allan I Levey, Erik C B Johnson, Nicholas T Seyfried, John Ringman, Anne M Fagan, Hiroshi Mori, Colin Masters, James M Noble, Raquel Sanchez-Valle, Francisco Lopera Brain Communications, 2026
Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease Omar Abdelmoity, Julie K. Wisch, James T. Kennedy, Manu Goyal, Andrei Vlassenko, Shaney Flores, Benjamin L. Handen, Elizabeth Head, David Keator, Michael S. Rafii, Patrick Lao, Florence Lai, H. Diana Rosas, Sigan L. Hartley, Shahid Zaman, Adam M. Brickman, Dana Tudorascu, Joseph H. Lee, Ricardo Francisco Allegri, Sarah Keefe, Christian la Fougere, Jorge Llibre‐Guerra, Takeshi Ikeuchi, John C. Morris, Jee Hoon Roh, Gregory S. Day, Johannes Levin, Peter R. Schofield, Brian A. Gordon, Tammie L.S. Benzinger, Beau M. Ances, and Annals of Neurology, 2025
Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer Nils F. Trautwein, Sven Mattern, Martina Hinterleitner, Gerald Reischl, Ralf Schirrmacher, Volker Steger, Silvio Nadalin, Konstantin Nikolaou, Johannes Schwenck, Stephan Singer, Christian la Fougère Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2025
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia Jorge J. Llibre-Guerra, M. Victoria Fernandez, Nelly Joseph-Mathurin, Shijia Bian, Kathleen Carter, Yan Li, Andrew J. Aschenbrenner, Cyril Pottier, Wendy Sigurdson, Eric McDade, Brian A. Gordon, Alan E. Renton, Tammie L. S. Benzinger, Laura Ibañez, Nico Barthelemy, Matthew Johnson, Jason Hassenstab, Guoqiao Wang, Alison M. Goate, Dan Western, Ciyang Wang, Diana Hobbs, Alisha Daniels, Celeste Karch, John C. Morris, Carlos Cruchaga, Erik C. B. Johnson, Randall J. Bateman, , David Aguillon, Ricardo F. Allegri, Ana Baena, Bryce Baker, Jessica Banks, Nicolas R. Barthélemy, Jamie Bartzel, Randall Bateman, Jacob A. Bechara, Sarah B. Berman, Yamile Bocanegra, William S. Brooks, David M. Cash, Allison Chen, Charles Chen, Jasmeer P. Chhatwal, Patricio Chrem Mendez, Laura Courtney, Alisha J. Daniels, Gregory S. Day, Emma Devenney, Anne M. Fagan, Martin Farlow, Shaney Flores, Nick C. Fox, Erin Franklin, Brian Fulton-Howard, Manu Goyal, Susanne Graber-Sultan, Neill R. Graff-Radford, Emily Gremminger, Cortaiga Hellm, David M. Holtzman, Russ Hornbeck, Edward D. Huey, Laura Ibanez, Takeshi Ikeuchi, Snezana Ikonomovic, Takanobu Ishiguro, Kenji Ishii, Kelley Jackson, Gina Jerome, Mathias Jucker, Celeste M. Karch, Kensaku Kasuga, Sarah Keefe, Deborah Koudelis, Elke Kuder-Buletta, Christian la Fougère, Christoph Laske, Jae-Hong Lee, Allan I. Levey, Johannes Levin, Yudy Milena Leon, Francisco Lopera, Ruijin Lu, Courtney Maa, Jacob Marsh, Mariana Martin, Ralph Martins, Parinaz Massoumzadeh, Colin Masters, Austin McCullough, Nicole McKay, Matthew Minton, Hiroshi Mori, Joyce Nicklaus, Yuzheng Nie, Yoshiki Niimi, James M. Noble, Ulrike Obermueller, Richard J. Perrin, Danielle M. Picarello, Christine Pulizos, Laura Ramirez, Gerald Reischl, John Ringman, Jacqueline Rizzo, Yvonne Rödenbeck, Jee Hoon Roh, Pedro Rosa-Neto, Natalie S. Ryan, Edita Sabaredzovic, Stephen Salloway, Raquel Sanchez-Valle, Peter R. Schofield, Jalen Scott, Michio Senda, Laura Serna, Nicholas T. Seyfried, Ashlee Simmons, Karina Skrbec, Jennifer Smith, Jennifer Stauber, Sarah Stout, Charlene Supnet-Bell, Ezequiel Surace, Reda Timofejavaite, Silvia Vazquez, Andrei Vlassenko, Jonathan Vöglein, Qing Wang, Yong Wang, Chengjie Xiong, Xiong Xu, Jinbin Xu, Angela Ziegemeier, Ellen Ziegemeier Nature Medicine, 2025
S3 Guideline for the diagnosis and treatment of hepatocellular carcinoma - Short version. Version 5.1 - August 2024 - AWMF Register No.: 032-053OL Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Katrin Borucki, Thomas Brunner, Reiner Caspari, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Jamila Gebert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Julia Ott, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Kristina Ringe, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Kerstin Schütte, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Jörg Trojan, Ingo van Thiel, Martin Utzig, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Gregor Wenzel, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2025
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Katrin Borucki, Thomas Brunner, Reiner Caspari, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Jamila Gebert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Julia Ott, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Kristina Ringe, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Kerstin Schütte, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Jörg Trojan, Ingo van Thiel, Martin Utzig, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Gregor Wenzel, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2025
S3 guideline for the diagnosis and treatment of biliary carcinomas - Long version. Version 5.1 - August 2024 - AWMF Register no.: 032-053OL Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Katrin Borucki, Thomas Brunner, Reiner Caspari, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Jamila Gebert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Julia Ott, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Kristina Ringe, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Kerstin Schütte, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Jörg Trojan, Ingo van Thiel, Martin Utzig, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Gregor Wenzel, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2025
S3 guideline for the diagnosis and treatment of biliary carcinomas - Short version. Version 5.1 - August 2024 - AWMF registration number: 032-053OL Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Katrin Borucki, Thomas Brunner, Reiner Caspari, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Jamila Gebert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Julia Ott, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Kristina Ringe, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Kerstin Schütte, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Jörg Trojan, Ingo van Thiel, Martin Utzig, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Gregor Wenzel, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2025
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients Dominik Sonanini, Johannes Schwenck, Simone Blaess, Julia Schmitt, Andreas Maurer, Walter Ehrlichmann, Malte Ritter, Julia Skokowa, Manfred Kneilling, Gundram Jung, Falko Fend, Simon Krost, Christian M. Seitz, Peter Lang, Gerald Reischl, Rupert Handgretinger, Christian la Fougère, Bernd J. Pichler Biomarker Research, 2024
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine Pauline Latzer, Henning Zelba, Florian Battke, Annekathrin Reinhardt, Borong Shao, Oliver Bartsch, Armin Rabsteyn, Johannes Harter, Martin Schulze, Thomas Okech, Alexander Golf, Christina Kyzirakos-Feger, Simone Kayser, Natalia Pieper, Magdalena Feldhahn, Julian Wünsche, Christian Seitz, Dirk Hadaschik, Claus Garbe, Till-Karsten Hauser, Christian la Fougère, Dirk Biskup, Dawn Brooke, David Parker, Uwe M. Martens, Gerald Illerhaus, Deborah T. Blumenthal, Ryan Merrell, Luisa Sánchez Lorenzo, Máté Hidvégi, Paula de Robles, Sied Kebir, William W. Li, Vincent W. Li, Matthew Williams, Alexandra M. Miller, Santosh Kesari, Michael Castro, Annick Desjardins, David M. Ashley, Henry S. Friedman, Patrick Y. Wen, Elisabeth C. Neil, Fabio M. Iwamoto, Bence Sipos, Karsten Geletneky, Lars Zender, Martin Glas, David A. Reardon, Saskia Biskup Nature Communications, 2024
Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease Anna Hofmann, Lisa M. Häsler, Marius Lambert, Stephan A. Kaeser, Susanne Gräber-Sultan, Ulrike Obermüller, Elke Kuder-Buletta, Christian la Fougere, Christoph Laske, Jonathan Vöglein, Johannes Levin, Nick C. Fox, Natalie S. Ryan, Henrik Zetterberg, Jorge J. Llibre-Guerra, Richard J. Perrin, Laura Ibanez, Peter R. Schofield, William S. Brooks, Gregory S. Day, Martin R. Farlow, Ricardo F. Allegri, Patricio Chrem Mendez, Takeshi Ikeuchi, Kensaku Kasuga, Jae-Hong Lee, Jee Hoon Roh, Hiroshi Mori, Francisco Lopera, Randall J. Bateman, Eric McDade, Brian A. Gordon, Jasmeer P. Chhatwal, Mathias Jucker, Stephanie A. Schultz, , David Aguillon, Andrew J. Aschenbrenner, Bryce Baker, Nicolas Barthelemy, Randall Bateman, Jacob A. Bechara, Tammie Benzinger, Sarah B. Berman, David M. Cash, Allison Chen, Charles Chen, Jasmeer P. Chhatwal Chhatwal, Patricio Chrem Mendez, Laura Courtney, Carlos Cruchaga, Alisha J. Daniels, Gregory S. Day, Anne M. Fagan, Martin Farlow, Shaney Flores, Erin Franklin, Alison M. Goate, Susanne Graber-Sultan, Neill R. Graff-Radford, Emily Gremminger, Jason Hassenstab, Elizabeth Herries, David M. Holtzman, Russ Hornbeck, Edward D. Huey, Snezana Ikonomovic, Kelley Jackson, Steve Jarman, Gina Jerome, Erik C. B. Johnson, Nelly Joseph-Mathurin, Celeste M. Karch, Sarah Keefe, Deborah Koudelis, Christoph Laske, Yudy Milena Leon, Allan I. Levey, Yan Li, Ruijin Lu, Jacob Marsh, Ralph Martins, Parinaz Massoumzadeh, Colin Masters, Austin McCullough, Eric McDade, Nicole McKay, Matthew Minton, John C. Morris, Neelesh K. Nadkarni, Joyce Nicklaus, Yoshiki Niimi, James M. Noble, Ulrike Obermueller, Danielle M. Picarello, Christine Pulizos, Laura Ramirez, Alan E. Renton, John Ringman, Jacqueline Rizzo, Yvonne Roedenbeck, Pedro Rosa-Neto, Edita Sabaredzovic, Stephen Salloway, Raquel Sanchez-Valle, Jalen Scott, Nicholas T. Seyfried, Ashlee Simmons, Jennifer Smith, Hunter Smith, Jennifer Stauber, Sarah Stout, Charlene Supnet-Bell, Ezequiel Surace, Silvia Vazquez, Jonathan Vöglein, Guoqiao Wang, Qing Wang, Chengie Xiong, Xiong Xu, Jinbin Xu Nature Communications, 2024
Results from the autoPET challenge on fully automated lesion segmentation in oncologic PET/CT imaging Sergios Gatidis, Marcel Früh, Matthias P. Fabritius, Sijing Gu, Konstantin Nikolaou, Christian La Fougère, Jin Ye, Junjun He, Yige Peng, Lei Bi, Jun Ma, Bo Wang, Jia Zhang, Yukun Huang, Lars Heiliger, Zdravko Marinov, Rainer Stiefelhagen, Jan Egger, Jens Kleesiek, Ludovic Sibille, Lei Xiang, Simone Bendazzoli, Mehdi Astaraki, Michael Ingrisch, Clemens C. Cyran, Thomas Küstner Nature Machine Intelligence, 2024
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma Justin Z. Wang, Vikas Patil, Alexander P. Landry, Chloe Gui, Andrew Ajisebutu, Jeff Liu, Olli Saarela, Stephanie L. Pugh, Minhee Won, Zeel Patel, Rebeca Yakubov, Ramneet Kaloti, Christopher Wilson, Aaron Cohen-Gadol, Mohamed A. Zaazoue, Ghazaleh Tabatabai, Marcos Tatagiba, Felix Behling, Damian A. Almiron Bonnin, Eric C. Holland, Tim J. Kruser, Jill S. Barnholtz-Sloan, Andrew E. Sloan, Craig Horbinski, Silky Chotai, Lola B. Chambless, Andrew Gao, Alexander D. Rebchuk, Serge Makarenko, Stephen Yip, Felix Sahm, Sybren L. N. Maas, Derek S. Tsang, , Michael W. McDermott, Thomas Santarius, Warren Selman, Marta Couce, Andrew E. Sloan, Bruno Carvalho, Patrick Y. Wen, Kyle M. Walsh, Eelke M. Bos, Wenya Linda Bi, Raymond Y. Huang, Priscilla K. Brastianos, Helen A. Shih, Tobias Walbert, Ian Lee, Michelle M. Felicella, Ana Valeria Castro, Houtan Noushmehr, James M. Snyder, Francesco Dimeco, Andrea Saladino, Bianca Pollo, Christian Schichor, Jörg-Christian Tonn, Felix Ehret, Timothy J. Kaufmann, Daniel H. Lachance, Caterina Giannini, Evanthia Galanis, Aditya Raghunathan, Michael A. Vogelbaum, Jill Barnholtz-Sloan, Patrick J. Cimino, Craig M. Horbinski, Mark Youngblood, Matija Snuderl, Sylvia C. Kurz, Erik P. Sulman, Ian F. Dunn, C. Oliver Hanemann, Mohsen Javadpour, Ho-Keung Ng, Paul C. Boutros, Richard G. Everson, Alkiviadis Tzannis, Konstantinos N. Fountas, Nils Ole Schmidt, Karolyn Au, Roland Goldbrunner, Norbert Galldiks, Marco Timmer, Tiit Illimar Mathiesen, Manfred Westphal, Katrin Lamszus, Franz L. Ricklefs, Christel Herold-Mende, Felix Sahm, Christine Jungk, Gerhard Jungwirth, Andreas von Deimling, Maximilian Deng, Susan C. Short, Michael D. Jenkinson, Christian Mawrin, Abdurrahman I. Islim, Daniel M. Fountain, Omar N. Pathmanaban, Katharine J. Drummond, Andrew Morokoff, David R. Raleigh, Arie Perry, Nicholas A. Butowski, Tathiane M. Malta, Viktor Zherebitskiy, Luke Hnenny, Gabriel Zada, Mirjam Renovanz, Antonio Santacroce, Christian la Fougère, Jens Schittenhelm, Paul Passlack, Jennifer Moliterno, Alper Dincer, C. Leland Rogers, Kenneth Aldape, Farshad Nassiri, Gelareh Zadeh Nature Medicine, 2024
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients Justin Z Wang, Alexander P Landry, David R Raleigh, Felix Sahm, Kyle M Walsh, Roland Goldbrunner, Leeor S Yefet, Jörg C Tonn, Chloe Gui, Quinn T Ostrom, Jill Barnholtz-Sloan, Arie Perry, Yosef Ellenbogen, C Oliver Hanemann, Gerhard Jungwirth, Michael D Jenkinson, Ghazaleh Tabatabai, Tiit I Mathiesen, Michael W McDermott, Marcos Tatagiba, Christian la Fougère, Sybren L N Maas, Norbert Galldiks, Nathalie L Albert, Priscilla K Brastianos, Felix Ehret, Giuseppe Minniti, Katrin Lamszus, Franz L Ricklefs, Jens Schittenhelm, Katharine J Drummond, Ian F Dunn, Omar N Pathmanaban, Aaron A Cohen-Gadol, Erik P Sulman, Emeline Tabouret, Emelie Le Rhun, Christian Mawrin, Jennifer Moliterno, Michael Weller, Wenya (Linda) Bi, Andrew Gao, Stephen Yip, Maximilian Niyazi, , Kenneth Aldape, Patrick Y Wen, Susan Short, Matthias Preusser, Farshad Nassiri, Gelareh Zadeh Neuro Oncology, 2024
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage Nelly Joseph‐Mathurin, Rebecca L. Feldman, Ruijin Lu, Zahra Shirzadi, Carmen Toomer, Junie R. Saint Clair, Yinjiao Ma, Nicole S. McKay, Jeremy F. Strain, Collin Kilgore, Karl A. Friedrichsen, Charles D. Chen, Brian A. Gordon, Gengsheng Chen, Russ C. Hornbeck, Parinaz Massoumzadeh, Austin A. McCullough, Qing Wang, Yan Li, Guoqiao Wang, Sarah J. Keefe, Stephanie A. Schultz, Carlos Cruchaga, Gregory M. Preboske, Clifford R. Jack, Jorge J. Llibre‐Guerra, Ricardo F. Allegri, Beau M. Ances, Sarah B. Berman, William S. Brooks, David M. Cash, Gregory S. Day, Nick C. Fox, Michael Fulham, Bernardino Ghetti, Keith A. Johnson, Mathias Jucker, William E. Klunk, Christian la Fougère, Johannes Levin, Yoshiki Niimi, Hwamee Oh, Richard J. Perrin, Gerald Reischl, John M. Ringman, Andrew J. Saykin, Peter R. Schofield, Yi Su, Charlene Supnet‐Bell, Jonathan Vöglein, Igor Yakushev, Adam M. Brickman, John C. Morris, Eric McDade, Chengjie Xiong, Randall J. Bateman, Jasmeer P. Chhatwal, Tammie L. S. Benzinger, and Alzheimer S and Dementia, 2024
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2024
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0 Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2024
T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease Farzaneh Rahmani, Matthew R. Brier, Brian A. Gordon, Nicole McKay, Shaney Flores, Sarah Keefe, Russ Hornbeck, Beau Ances, Nelly Joseph‐Mathurin, Chengjie Xiong, Guoqiao Wang, Cyrus A. Raji, Jorge J. Libre‐Guerra, Richard J. Perrin, Eric McDade, Alisha Daniels, Celeste Karch, Gregory S. Day, Adam M. Brickman, Michael Fulham, Clifford R. Jack, Christian la La Fougère, Gerald Reischl, Peter R. Schofield, Hwamee Oh, Johannes Levin, Jonathan Vöglein, David M. Cash, Igor Yakushev, Takeshi Ikeuchi, William E. Klunk, John C. Morris, Randall J. Bateman, Tammie L. S. Benzinger, and Human Brain Mapping, 2023
Big Field of View MRI T1w and FLAIR Template - NMRI225 Barbara A. K. Kreilkamp, Pascal Martin, Benjamin Bender, Christian la Fougère, Daniel van de Velden, Christina Stier, Silke Ethofer, Raviteja Kotikalapudi, Justus Marquetand, Erik H. Rauf, Markus Loose, Niels K. Focke Scientific Data, 2023
S3 guideline "Diagnosis and treatment of hepatocellular carcinoma" - Long version 4.0 Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2023
S3 guideline "Diagnosis and treatment of hepatocellular carcinoma" - Short version Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2023
Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN) Nicole S. McKay, Brian A. Gordon, Russ C. Hornbeck, Aylin Dincer, Shaney Flores, Sarah J. Keefe, Nelly Joseph-Mathurin, Clifford R. Jack, Robert Koeppe, Peter R. Millar, Beau M. Ances, Charles D. Chen, Alisha Daniels, Diana A. Hobbs, Kelley Jackson, Deborah Koudelis, Parinaz Massoumzadeh, Austin McCullough, Michael L. Nickels, Farzaneh Rahmani, Laura Swisher, Qing Wang, Ricardo F. Allegri, Sarah B. Berman, Adam M. Brickman, William S. Brooks, David M. Cash, Jasmeer P. Chhatwal, Gregory S. Day, Martin R. Farlow, Christian la Fougère, Nick C. Fox, Michael Fulham, Bernardino Ghetti, Neill Graff-Radford, Takeshi Ikeuchi, William Klunk, Jae-Hong Lee, Johannes Levin, Ralph Martins, Colin L. Masters, Jonathan McConathy, Hiroshi Mori, James M. Noble, Gerald Reischl, Christopher Rowe, Stephen Salloway, Raquel Sanchez-Valle, Peter R. Schofield, Hiroyuki Shimada, Mikio Shoji, Yi Su, Kazushi Suzuki, Jonathan Vöglein, Igor Yakushev, Carlos Cruchaga, Jason Hassenstab, Celeste Karch, Eric McDade, Richard J. Perrin, Chengjie Xiong, John C. Morris, Randall J. Bateman, Tammie L. S. Benzinger, Adam. M. Brickman, Christian la Fougère, and Nature Neuroscience, 2023
Advances in PET imaging of cancer Johannes Schwenck, Dominik Sonanini, Jonathan M. Cotton, Hans-Georg Rammensee, Christian la Fougère, Lars Zender, Bernd J. Pichler Nature Reviews Cancer, 2023
Radioligand therapies in cancer: mapping the educational landscape in Europe Valentina Bugani, Luca Battistelli, Maddalena Sansovini, Manuela Monti, Giovanni Paganelli, Ignasi Gich, Albert Flotats, Paola Anna Erba, Jean-Yves Blay, Christian la Fougère, Hendrik Van Poppel, Andreas Charalambous, Ken Herrmann, Alessandro Giordano, Tamás Györke, Christophe Deroose, Federica Matteucci, Ignasi Carrió European Journal of Nuclear Medicine and Molecular Imaging, 2023
S3 guideline on the diagnosis and treatment of biliary carcinomas - short version Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2023
First-in-Humans PET/MRI of in Vivo GD2 Expression in Osteosarcoma Nils Florian Trautwein, Gerald Reischl, Christian Seitz, Helmut Dittmann, Ferdinand Seith, Sophia Scheuermann, Tobias Feuchtinger, Frank Dombrowski, Rupert Handgretinger, Jörg Fuchs, Bernd Pichler, Christian la Fougère, Johannes Schwenck Journal of Nuclear Medicine, 2023
S3 guideline on the diagnosis and treatment of biliary carcinomas - long version Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek Zeitschrift Fur Gastroenterologie, 2023
Long-term prognostic factors for PRRT in neuroendocrine tumors Nils Florian Trautwein, Johannes Schwenck, Johann Jacoby, Gerald Reischl, Francesco Fiz, Lars Zender, Helmut Dittmann, Martina Hinterleitner, Christian la Fougère Frontiers in Medicine, 2023
Covariance-based vs. correlation-based functional connectivity dissociates healthy aging from Alzheimer disease Jeremy F. Strain, Matthew R. Brier, Aaron Tanenbaum, Brian A. Gordon, John E. McCarthy, Aylin Dincer, Daniel S. Marcus, Jasmeer P. Chhatwal, Neill R. Graff-Radford, Gregory S. Day, Christian la Fougère, Richard J. Perrin, Stephen Salloway, Peter R. Schofield, Igor Yakushev, Takeshi Ikeuchi, Jonathan Vöglein, John C. Morris, Tammie L.S. Benzinger, Randall J. Bateman, Beau M. Ances, Abraham Z. Snyder Neuroimage, 2022
S3 Guideline - Diagnosis and treatment of biliary carcinomas: Long version 2.0 - June 2021 - AWMF Register No.: 032-053OL M. Bitzer, S. Voesch, J. Albert, P. Bartenstein, W. Bechstein, S. Blödt, T. Brunner, F. Dombrowski, M. Evert, M. Follmann, C. La Fougère, P. Freudenberger, A. Geier, E. Gkika, M. Götz, E. Hammes, T. Helmberger, R. T. Hoffmann, W. P. Hofmann, P. Huppert, A. Kautz, G. Knötgen, J. Körber, D. Krug, F. Lammert, H. Lang, T. Langer, P. Lenz, A. Mahnken, A. Meining, O. Micke, S. Nadalin, H. P. Nguyen, J. Ockenga, K. Oldhafer, P. Paprottka, K. Paradies, P. Pereira, T. Persigehl, M. Plauth, R. Plentz, J. Pohl, J. Riemer, P. Reimer, J. Ringwald, U. Ritterbusch, E. Roeb, B. Schellhaas, P. Schirmacher, I. Schmid, A. Schuler, D. von Schweinitz, D. Seehofer, M. Sinn, A. Stein, A. Stengel, N. Steubesand, C. Stoll, A. Tannapfel, A. Taubert, J. Trojan, I. van Thiel, R. Tholen, A. Vogel, T. Vogl, H. Vorwerk, F. Wacker, O. Waidmann, H. Wedemeyer, H. Wege, D. Wildner, C. Wittekind, M. A. Wörns, P. Galle, N. Malek Zeitschrift Fur Gastroenterologie, 2022
S3 guideline: Diagnosis and treatment of biliary carcinomas - Short version 2.00 - June 2021, AWMF Register no.: 032-053OL M. Bitzer, S. Voesch, J. Albert, P. Bartenstein, W. Bechstein, S. Blödt, T. Brunner, F. Dombrowski, M. Evert, M. Follmann, C. La Fougère, P. Freudenberger, A. Geier, E. Gkika, M. Götz, E. Hammes, T. Helmberger, R. T. Hoffmann, W. P. Hofmann, P. Huppert, A. Kautz, G. Knötgen, J. Körber, D. Krug, F. Lammert, H. Lang, T. Langer, P. Lenz, A. Mahnken, A. Meining, O. Micke, S. Nadalin, H. P. Nguyen, J. Ockenga, K. Oldhafer, P. Paprottka, K. Paradies, P. Pereira, T. Persigehl, M. Plauth, R. Plentz, J. Pohl, J. Riemer, P. Reimer, J. Ringwald, U. Ritterbusch, E. Roeb, B. Schellhaas, P. Schirmacher, I. Schmid, A. Schuler, D. von Schweinitz, D. Seehofer, M. Sinn, A. Stein, A. Stengel, N. Steubesand, C. Stoll, A. Tannapfel, A. Taubert, J. Trojan, I. van Thiel, R. Tholen, A. Vogel, T. Vogl, H. Vorwerk, F. Wacker, O. Waidmann, H. Wedemeyer, H. Wege, D. Wildner, C. Wittekind, M. A. Wörns, P. Galle, N. Malek Zeitschrift Fur Gastroenterologie, 2022
Central Insulin Modulates Dopamine Signaling in the Human Striatum Stephanie Kullmann, Dominik Blum, Benjamin Assad Jaghutriz, Christoph Gassenmaier, Benjamin Bender, Hans-Ulrich Häring, Gerald Reischl, Hubert Preissl, Christian la Fougère, Andreas Fritsche, Matthias Reimold, Martin Heni Journal of Clinical Endocrinology and Metabolism, 2021
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer, Timo Manz, Martin Pflügler, Andreas Maurer, Jonas S Heitmann, Ilona Hagelstein, Melanie Märklin, Sebastian Hörner, Tilmann Todenhöfer, Carsten Calaminus, Arnulf Stenzl, Bernd Pichler, Christian Fougère, Marc A Schneider, Hans‐Georg Rammensee, Lars Zender, Bence Sipos, Helmut R Salih, Gundram Jung EMBO Molecular Medicine, 2021
Machine learning identifies stroke features between species Salvador Castaneda-Vega, Prateek Katiyar, Francesca Russo, Kristin Patzwaldt, Luisa Schnabel, Sarah Mathes, Johann-Martin Hempel, Ursula Kohlhofer, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Ulf Ziemann, Christian la Fougere, Ulrike Ernemann, Bernd J. Pichler, Jonathan A. Disselhorst, Sven Poli Theranostics, 2021
Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease Ophir Keret, A. Staffaroni, J. Ringman, Y. Cobigo, Sheng-Yang M. Goh, A. Wolf, I. Allen, S. Salloway, J. Chhatwal, A. Brickman, D. Reyes‐Dumeyer, R. Bateman, T. Benzinger, J. Morris, B. Ances, N. Joseph-Mathurin, R. Perrin, B. Gordon, J. Levin, J. Vöglein, M. Jucker, C. la Fougère, R. Martins, H. Sohrabi, K. Taddei, V. Villemagne, P. Schofield, W. Brooks, M. Fulham, C. Masters, B. Ghetti, A. Saykin, C. Jack, N. Graff-Radford, M. Weiner, D. Cash, R. Allegri, Patricio Chrem, Su Yi, B. Miller, G. Rabinovici, H. Rosen Alzheimer S and Dementia Diagnosis Assessment and Disease Monitoring, 2021
PET/MRI and genetic intrapatient heterogeneity in head and neck cancers Kerstin Clasen, Sara Leibfarth, Franz J. Hilke, Jakob Admard, René M. Winter, Stefan Welz, Sergios Gatidis, Dominik Nann, Stephan Ossowski, Thomas Breuer, Christian la Fougère, Konstantin Nikolaou, Olaf Riess, Daniel Zips, Christopher Schroeder, Daniela Thorwarth Strahlentherapie Und Onkologie, 2020
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial Ursula Nestle, Tanja Schimek-Jasch, Stephanie Kremp, Andrea Schaefer-Schuler, Michael Mix, Andreas Küsters, Marco Tosch, Thomas Hehr, Susanne Martina Eschmann, Yves-Pierre Bultel, Peter Hass, Jochen Fleckenstein, Alexander Thieme, Marcus Stockinger, Karin Dieckmann, Matthias Miederer, Gabriele Holl, H Christian Rischke, Eleni Gkika, Sonja Adebahr, Jochem König, Anca-Ligia Grosu, A L Grosu, W Weber, P Meyer, H Hoffmanns, U Nestle, R Aurisch, W Schäfer, T Hehr, S M Eschmann, W Dornoff, B Siekmeyer, L Trampert, G Gademann, T Brunner, A Amthauer, J Ricke, M Pech, C Rübe, C M Kirsch, S Ezzidin, H Schmidberger, M Schreckenberger, M Bamberg, D Zips, R Bares, C La Fougere, V Budach, W Brenner, M Beck, R Freiherr von Gumppenberg, D Aebersold, T Krause, H J Feldmann, A Hertel, G Stüben, J Sciuk, H Annweiler, G Holl, W Oehler, I Schlöcker, R Baum, B Kimmig, J Dunst, E Henze, U Lützen, M Schwaiger, K Strehle, W Alberti, M Piroth, M Tosch, R Pötter, J Widder, C Herold, U Freund, F Momm, W Weber, M L Sautter-Bihl, K Tatsch, G Hildebrandt, B Krause Lancet Oncology, 2020
Real-space navigation testing differentiates between amyloid-positive and -negative aMCI Florian Schöberl, Cauchy Pradhan, Stephanie Irving, Katharina Buerger, Guoming Xiong, Günter Kugler, Stefan Kohlbecher, Julia Engmann, Philipp Werner, Matthias Brendel, Erich Schneider, Robert Perneczky, Klaus Jahn, Christian la Fougère, Peter Bartenstein, Thomas Brandt, Marianne Dieterich, Andreas Zwergal Neurology, 2020
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease Aylin Dincer, Brian A. Gordon, Amrita Hari-Raj, Sarah J. Keefe, Shaney Flores, Nicole S. McKay, Angela M. Paulick, Kristine E. Shady Lewis, Rebecca L. Feldman, Russ C. Hornbeck, Ricardo Allegri, Beau M. Ances, Sarah B. Berman, Adam M. Brickman, William S. Brooks, David M. Cash, Jasmeer P. Chhatwal, Martin R. Farlow, Christian la Fougère, Nick C. Fox, Michael J. Fulham, Clifford R. Jack, Nelly Joseph-Mathurin, Celeste M. Karch, Athene Lee, Johannes Levin, Colin L. Masters, Eric M. McDade, Hwamee Oh, Richard J. Perrin, Cyrus Raji, Stephen P. Salloway, Peter R. Schofield, Yi Su, Victor L. Villemagne, Qing Wang, Michael W. Weiner, Chengjie Xiong, Igor Yakushev, John C. Morris, Randall J. Bateman, Tammie L.S. Benzinger Neuroimage Clinical, 2020
Joint imaging platform for federated clinical data analytics Jonas Scherer, Marco Nolden, Jens Kleesiek, Jasmin Metzger, Klaus Kades, Verena Schneider, Michael Bach, Oliver Sedlaczek, Andreas M. Bucher, Thomas J. Vogl, Frank Grünwald, Jens-Peter Kühn, Ralf-Thorsten Hoffmann, Jörg Kotzerke, Oliver Bethge, Lars Schimmöller, Gerald Antoch, Hans-Wilhelm Müller, Andreas Daul, Konstantin Nikolaou, Christian la Fougère, Wolfgang G. Kunz, Michael Ingrisch, Balthasar Schachtner, Jens Ricke, Peter Bartenstein, Felix Nensa, Alexander Radbruch, Lale Umutlu, Michael Forsting, Robert Seifert, Ken Herrmann, Philipp Mayer, Hans-Ulrich Kauczor, Tobias Penzkofer, Bernd Hamm, Winfried Brenner, Roman Kloeckner, Christoph Düber, Mathias Schreckenberger, Rickmer Braren, Georgios Kaissis, Marcus Makowski, Matthias Eiber, Andrei Gafita, Rupert Trager, Wolfgang A. Weber, Jakob Neubauer, Marco Reisert, Michael Bock, Fabian Bamberg, Jürgen Hennig, Philipp Tobias Meyer, Juri Ruf, Uwe Haberkorn, Stefan O. Schoenberg, Tristan Kuder, Peter Neher, Ralf Floca, Heinz-Peter Schlemmer, Klaus Maier-Hein JCO Clinical Cancer Informatics, 2020
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer Hans-Georg Rammensee, Karl-Heinz Wiesmüller, P. Anoop Chandran, Henning Zelba, Elisa Rusch, Cécile Gouttefangeas, Daniel J. Kowalewski, Moreno Di Marco, Sebastian P. Haen, Juliane S. Walz, Yamel Cardona Gloria, Johanna Bödder, Jill-Marie Schertel, Antje Tunger, Luise Müller, Maximilian Kießler, Rebekka Wehner, Marc Schmitz, Meike Jakobi, Nicole Schneiderhan-Marra, Reinhild Klein, Karoline Laske, Kerstin Artzner, Linus Backert, Heiko Schuster, Johannes Schwenck, Alexander N. R. Weber, Bernd J. Pichler, Manfred Kneilling, Christian la Fougère, Stephan Forchhammer, Gisela Metzler, Jürgen Bauer, Benjamin Weide, Wilfried Schippert, Stefan Stevanović, Markus W. Löffler Journal for Immunotherapy of Cancer, 2019
Imaging and diagnostic advances for intracranial meningiomas Raymond Y Huang, Wenya Linda Bi, Brent Griffith, Timothy J Kaufmann, Christian la Fougère, Nils Ole Schmidt, Jöerg C Tonn, Michael A Vogelbaum, Patrick Y Wen, Kenneth Aldape, Farshad Nassiri, Gelareh Zadeh, Ian F Dunn, International Consortium on Meningiomas, Kenneth Aldape, Karolyn Au, Jill Barnhartz-Sloan, Wenya Linda Bi, Priscilla K Brastianos, Nicholas Butowski, Carlos Carlotti, Michael D Cusimano, Francesco DiMeco, Katharine Drummond, Ian F Dunn, Evanthia Galanis, Caterina Giannini, Roland Goldbrunner, Brent Griffith, Rintaro Hashizume, C Oliver Hanemann, Christel Herold-Mende, Craig Horbinski, Raymond Y Huang, David James, Michael D Jenkinson, Christine Jungk, Timothy J Kaufman, Boris Krischek, Daniel Lachance, Christian Lafougère, Ian Lee, Jeff C Liu, Yasin Mamatjan, Alireza Mansouri, Christian Mawrin, Michael McDermott, David Munoz, Farshad Nassiri, Houtan Noushmehr, Ho-Keung Ng, Arie Perry, Farhad Pirouzmand, Laila M Poisson, Bianca Pollo, David Raleigh, Felix Sahm, Andrea Saladino, Thomas Santarius, Christian Schichor, David Schultz, Nils O Schmidt, Warren Selman, Andrew Sloan, Julian Spears, James Snyder, Suganth Suppiah, Ghazaleh Tabatabai, Marcos Tatagiba, Daniela Tirapelli, Joerg C Tonn, Derek Tsang, Michael A Vogelbaum, Andreas von Deimling, Patrick Y Wen, Tobias Walbert, Manfred Westphal, Adriana M Workewych, Gelareh Zadeh Neuro Oncology, 2019
Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCAN TM ) Klaus Tatsch, Ralph Buchert, Peter Bartenstein, Henryk Barthel, Henning Boecker, Peter Brust, Alexander Drzezga, Christian la Fougère, Gerhard Gründer, Frank Grünwald, Bernd-J. Krause, Torsten Kuwert, Karl-Josef Langen, Axel Rominger, Osama Sabri, Mathias Schreckenberger, Philipp T. Meyer Nuklearmedizin, 2019
Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM) on behalf of the European Society of Cardiovascular Radiology (ESCR), Felix Nensa, the European Association of Nuclear Medicine (EANM) Cardiovascular Committee, Fabian Bamberg, Christoph Rischpler, Leon Menezes, Thorsten D. Poeppel, Christian la Fougère, Dietrich Beitzke, Sazan Rasul, Christian Loewe, Konstantin Nikolaou, Jan Bucerius, Andreas Kjaer, Matthias Gutberlet, Niek H. Prakken, Rozemarijn Vliegenthart, Riemer H. J. A. Slart, Stephan G. Nekolla, Martin L. Lassen, Bernd J. Pichler, Thomas Schlosser, Alexis Jacquier, Harald H. Quick, Michael Schäfers, Marcus Hacker European Journal of Hybrid Imaging, 2018
Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM) on behalf of the European Society of Cardiovascular Radiology (ESCR), Felix Nensa, the European Association of Nuclear Medicine (EANM) Cardiovascular Committee, Fabian Bamberg, Christoph Rischpler, Leon Menezes, Thorsten D. Poeppel, Christian la Fougère, Dietrich Beitzke, Sazan Rasul, Christian Loewe, Konstantin Nikolaou, Jan Bucerius, Andreas Kjaer, Matthias Gutberlet, Niek H. Prakken, Rozemarijn Vliegenthart, Riemer H. J. A. Slart, Stephan G. Nekolla, Martin L. Lassen, Bernd J. Pichler, Thomas Schlosser, Alexis Jacquier, Harald H. Quick, Michael Schäfers, Marcus Hacker European Radiology, 2018
Prediction of non-sentinel lymph node metastases after positive sentinel lymph nodes using nomograms INES GRUBER, MAJA HENZEL, BIRGITT SCHÖNFISCH, ANNETTE STÄBLER, FLORIN-ANDREI TARAN, MARKUS HAHN, CARMEN RÖHM, GISELA HELMS, ERNST OBERLECHNER, BENJAMIN WIESINGER, KONSTANTIN NIKOLAOU, CHRISTIAN LA FOUGÈRE, DIETHELM WALLWIENER, ANDREAS HARTKOPF, NATALIA KRAWCZYK, TANJA FEHM, SARA BRUCKER Anticancer Research, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study Brian A Gordon, Tyler M Blazey, Yi Su, Amrita Hari-Raj, Aylin Dincer, Shaney Flores, Jon Christensen, Eric McDade, Guoqiao Wang, Chengjie Xiong, Nigel J Cairns, Jason Hassenstab, Daniel S Marcus, Anne M Fagan, Clifford R Jack, Russ C Hornbeck, Katrina L Paumier, Beau M Ances, Sarah B Berman, Adam M Brickman, David M Cash, Jasmeer P Chhatwal, Stephen Correia, Stefan Förster, Nick C Fox, Neill R Graff-Radford, Christian la Fougère, Johannes Levin, Colin L Masters, Martin N Rossor, Stephen Salloway, Andrew J Saykin, Peter R Schofield, Paul M Thompson, Michael M Weiner, David M Holtzman, Marcus E Raichle, John C Morris, Randall J Bateman, Tammie L S Benzinger Lancet Neurology, 2018
Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany D. L. Bailey, B. J. Pichler, B. Gückel, G. Antoch, H. Barthel, Z. M. Bhujwalla, S. Biskup, S. Biswal, M. Bitzer, R. Boellaard, R. F. Braren, C. Brendle, K. Brindle, A. Chiti, C. la Fougère, R. Gillies, V. Goh, M. Goyen, M. Hacker, L. Heukamp, G. M. Knudsen, A. M. Krackhardt, I. Law, J. C. Morris, K. Nikolaou, J. Nuyts, A. A. Ordonez, K. Pantel, H. H. Quick, K. Riklund, O. Sabri, B. Sattler, E. G. C. Troost, M. Zaiss, L. Zender, Thomas Beyer Molecular Imaging and Biology, 2018
Decoding intratumoral heterogeneity of breast cancer by multiparametric in vivo imaging: A translational study Jennifer Schmitz, Julian Schwab, Johannes Schwenck, Qian Chen, Leticia Quintanilla-Martinez, Markus Hahn, Beate Wietek, Nina Schwenzer, Annette Staebler, Ursula Kohlhofer, Olulanu H. Aina, Neil E. Hubbard, Gerald Reischl, Alexander D. Borowsky, Sara Brucker, Konstantin Nikolaou, Christian la Fougère, Robert D. Cardiff, Bernd J. Pichler, Andreas M. Schmid Cancer Research, 2016
Towards tracer dose reduction in PET studies: Simulation of dose reduction by retrospective randomized undersampling of list-mode data Hellenic Journal of Nuclear Medicine, 2016
German society of nuclear medicine procedure guideline on Beta-amyloid brain PET imaging Philipp Meyer, Alexander Drzezga, Peter Bartenstein, Henning Boecker, Peter Brust, Ralph Buchert, Heinz Coenen, Christian la Fougère, Gerhard Gründer, Frank Grünwald, Bernd Krause, Torsten Kuwert, Matthias Schreckenberger, Klaus Tatsch, Karl-Josef Langen, Osama Sabri, Henryk Barthel Nuklearmedizin, 2016
PET/MR in Oncology Ferdinand Seith, Sergios Gatidis, Sotirios Bisdas, Christian la Fougère, Jürgen Schäfer, Konstantin Nikolaou, Nina Schwenzer Current Radiology Reports, 2015
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM Bogdana Suchorska, Nathalie L. Jansen, Jennifer Linn, Hans Kretzschmar, Hendrik Janssen, Sabina Eigenbrod, Matthias Simon, Gabriele Pöpperl, Friedrich W. Kreth, Christian la Fougere, Michael Weller, Joerg C. Tonn, For the German Glioma Network, Bogdana Suchorska, Nathalie Lisa Jansen, Jennifer Linn, Hans Kretzschmar, Hendrik Janssen, Sabina Eigenbrod, Matthias Simon, Gabriele Pöpperl, Friedrich Wilhelm Kreth, Christian La Fougere, Michael Weller, Joerg Christian Tonn, Oliver Schnell, Julia Geisler, Bettina Henschel Neurology, 2015
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients Nathalie L. Jansen, Bogdana Suchorska, Vera Wenter, Sabina Eigenbrod, Christine Schmid-Tannwald, Andreas Zwergal, Maximilian Niyazi, Mark Drexler, Peter Bartenstein, Oliver Schnell, Jörg-Christian Tonn, Niklas Thon, Friedrich-Wilhelm Kreth, Christian la Fougère Journal of Nuclear Medicine, 2014
Diffuse leukoencephalopathy with spheroids: Biopsy findings and a novel mutation Johannes Levin, Steffen Tiedt, Thomas Arzberger, Saskia Biskup, Madeleine Schuberth, Gisela Stenglein-Krapf, Friedrich-Wilhelm Kreth, Tobias Högen, Christian la Fougère, Jennifer Linn, Marjo S. van der Knaap, Armin Giese, Hans A. Kretzschmar, Adrian Danek Clinical Neurology and Neurosurgery, 2014
MRI-suspected low-grade glioma: Is there a need to perform dynamic FET PET? Nathalie L. Jansen, Vera Graute, Lena Armbruster, Bogdana Suchorska, Juergen Lutz, Sabina Eigenbrod, Paul Cumming, Peter Bartenstein, Jörg-Christian Tonn, Friedrich Wilhelm Kreth, Christian la Fougère European Journal of Nuclear Medicine and Molecular Imaging, 2012
Irradiation and bevacizumab in high-grade glioma retreatment settings Maximilian Niyazi, Ute Ganswindt, Silke Birgit Schwarz, Friedrich-Wilhelm Kreth, Jörg-Christian Tonn, Julia Geisler, Christian la Fougère, Lorenz Ertl, Jennifer Linn, Axel Siefert, Claus Belka International Journal of Radiation Oncology Biology Physics, 2012
Functional representation of olfactory impairment in early alzheimer's disease Stefan Förster, Andreas Vaitl, Stefan J. Teipel, Igor Yakushev, Mona Mustafa, Christian la Fougère, Axel Rominger, Paul Cumming, Peter Bartenstein, Harald Hampel, Thomas Hummel, Katharina Buerger, Walter Hundt, Silke Steinbach Journal of Alzheimer S Disease, 2010
Radioembolization in Patients with Hepatic Metastases from Breast Cancer Tobias F. Jakobs, Ralf-Thorsten Hoffmann, Ton Fischer, Hans-Joachim Stemmler, Klaus Tatsch, Christian La Fougere, Ravi Murthy, Maximillian F. Reiser, Thomas K. Helmberger Journal of Vascular and Interventional Radiology, 2008
Ictal SPECT in Sturge-Weber syndrome Özgür Bilgin, Christian Vollmar, Aurelia Peraud, Christian la Fougere, Pedro Beleza, Soheyl Noachtar Epilepsy Research, 2008
D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: A 123I-iodobenzamide SPECT study Journal of Nuclear Medicine, 2005
Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0 H Barthel, M Brendel, N Albert, H Boecker, C Bouter, J Brumberg, ... Nuklearmedizin-NuclearMedicine 65 (03), 223-235 , 2026 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association study M Patel, W Feng, NS Mckay, PR Millar, M Liu, C Yang, A Cetin, ... The Lancet Neurology 25 (6), 581-590 , 2026 2026 Citations: 1
A longitudinal whole-body CT dataset with manually annotated tumor lesions S Gatidis, F Peisen, A Wagner, POM Choudja, A Othman, A Sanner, ... Scientific Data , 2026 2026
The inflammatory fingerprint reveals immune cell populations associated with disease activity in cardiac sarcoidosis T Harm, SE Autenrieth, K Mezger, AK Rohlfing, H Dittman, C la Fougère, ... Clinical Research in Cardiology, 1-14 , 2026 2026
The autoPET3 Challenge--Automated Lesion Segmentation in Whole-Body PET/CT-Multitracer Multicenter Generalization J Dexl, K Jeblick, A Mittermeier, B Schachtner, AT Stüber, J Topalis, ... arXiv preprint arXiv:2605.05775 , 2026 2026
Continuous bed motion versus step-and-shoot acquisition in LAFOV PET/CT: insights from multi-phantom and patient studies PM Linder, W Lan, E Calderón, I Rausch, C la Fougère, FP Schmidt EJNMMI Physics , 2026 2026
Beyond image quality: Patient experience with long-axial field-of-view and standard PET/CT systems D Sauerbrunn, N Schäffeler, J Sekler, J Jacoby, K Nikolaou, C la Fougère, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-15 , 2026 2026
Characterization of metabolic tumor kinetics in head and neck squamous cell carcinoma using ultra-late [18F] FDG PET imaging E Calderón, P Pelz, J von Fraunberg, S Böke, M Weissinger, H Dittmann, ... Nuklearmedizin-NuclearMedicine 65 (02), P24 , 2026 2026
Real-world experience with lutetium (177Lu) vipivotide tetraxetan (177Lu-PSMA-617) in metastatic castration resistant prostate cancer (mCRPC): Results from the first interim … K Herrmann, C la Fougère, T Winkens, A Buck, F Zengerling Nuklearmedizin-NuclearMedicine 65 (02), V77 , 2026 2026
Prognostic value of [64Cu] GD2 PET beyond [18F] FDG PET in sarcoma patients N Trautwein, H Dittmann, S Kailayangiri, CKW Deinzer, G Reischl, P Lang, ... Nuklearmedizin-NuclearMedicine 65 (02), V8 , 2026 2026
PET-basierte prognostische Faktoren für mCRPC Patienten mit viszeralen Metastasen unter [177Lu] Lu-PSMA RLT M Späth, H Dittmann, R Spallek, E Calderon, J Mück, A Brendlin, ... Nuklearmedizin-NuclearMedicine 65 (02), P65 , 2026 2026
Einsatz Somatostatinrezeptor (SSTR)-gerichteter Radioligandentherapie (RLT) bei Patienten mit pankreatischen neuroendokrinen Tumoren (panNET) in Deutschland M Schmidt, N Trautwein, C la Fougère, B Kreppel, M Essler, C Däubler, ... Nuklearmedizin-NuclearMedicine 65 (02), V38 , 2026 2026
Histologische ex vivo Validierung von [18F] SiTATE für SSTR-PET bei Meningeomen R Gerdes, J Schittenhelm, S Singer, B Bender, C la Fougère, N Trautwein Nuklearmedizin-NuclearMedicine 65 (02), P20 , 2026 2026
Longitudinal subcortical volume changes and their correlations with multiple PET and fluid biomarkers in dominantly inherited Alzheimer’s disease ILH Choo, H Park, BA Gordon, RJ Bateman, R Bateman, AJ Daniels, ... The Journal of Prevention of Alzheimer's Disease 13 (4), 100513 , 2026 2026
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic … FL Giesel, SA Koerber, B Hadaschik, S Kiefer, S Schwarzenboeck, ... European journal of nuclear medicine and molecular imaging 53 (5), 2994-3006 , 2026 2026
AutoPET challenge on fully automated lesion segmentation in oncologic PET/CT imaging, part 2: domain generalization J Dexl, S Gatidis, M Früh, K Jeblick, A Mittermeier, AT Stüber, ... Journal of Nuclear Medicine 67 (3), 481-488 , 2026 2026 Citations: 5
Exploring extended [ 18 F]FDG kinetics in lymphoma with ultra-late LAFOV-PET/CT M Weissinger, S Ursprung, J Jacoby, J Vogel, E Calderón, B Gückel, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-12 , 2026 2026
Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity—A Case Report RD Lewetag, K Kluthe, NF Trautwein, UM Lauer, C la Fougère, B Sipos, ... Current Oncology 33 (2), 105 , 2026 2026
Advancing Automated Lesion Segmentation Toward Clinical Integration in Oncologic PET/CT POM Choudja, J Dexl, M Frueh, K Jeblick, A Mittermeier, AT Stueber, ... ONCOLOGY RESEARCH AND TREATMENT 49, 237-237 , 2026 2026
PET-imaging derived prognostic factors for prostate cancer patients with visceral metastases receiving [177Lu] Lu-PSMA radiopharmaceutical therapy (RPT) MS Späth, H Dittmann, R Spallek, E Calderón, J Mück, A Brendlin, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-8 , 2026 2026
MOST CITED SCHOLAR PUBLICATIONS
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ... Neuro-oncology 18 (9), 1199-1208 , 2016 2016 Citations: 877
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ... The Lancet Neurology 17 (3), 241-250 , 2018 2018 Citations: 740
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [ 18 F]FDG: version … I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, ... European journal of nuclear medicine and molecular imaging 46 (3), 540-557 , 2019 2019 Citations: 617
Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison C La Fougere, A Zwergal, A Rominger, S Förster, G Fesl, M Dieterich, ... Neuroimage 50 (4), 1589-1598 , 2010 2010 Citations: 532
Attention deficit hyperactivity disorder: binding of [ 99m Tc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment S Dresel, J Krause, KH Krause, C LaFougere, K Brinkbäumer, HF Kung, ... European journal of nuclear medicine 27 (10), 1518-1524 , 2000 2000 Citations: 397
A whole-body FDG-PET/CT dataset with manually annotated tumor lesions S Gatidis, T Hepp, M Früh, C La Fougère, K Nikolaou, C Pfannenberg, ... Scientific Data 9 (1), 601 , 2022 2022 Citations: 395
Molecular imaging of gliomas with PET: opportunities and limitations C la Fougere, B Suchorska, P Bartenstein, FW Kreth, JC Tonn Neuro-oncology 13 (8), 806-819 , 2011 2011 Citations: 374
PET and SPECT in epilepsy: a critical review C La Fougère, A Rominger, S Förster, J Geisler, P Bartenstein Epilepsy & Behavior 15 (1), 50-55 , 2009 2009 Citations: 333
Comparison of 68 Ga-labelled PSMA-11 and 11 C-choline in the detection of prostate cancer metastases by PET/CT J Schwenck, H Rempp, G Reischl, S Kruck, A Stenzl, K Nikolaou, ... European journal of nuclear medicine and molecular imaging 44 (1), 92-101 , 2017 2017 Citations: 325
Advances in PET imaging of cancer J Schwenck, D Sonanini, JM Cotton, HG Rammensee, C la Fougère, ... Nature Reviews Cancer 23 (7), 474-490 , 2023 2023 Citations: 314
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ... Neuro-oncology 21 (7), 901-910 , 2019 2019 Citations: 284
Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas M Kunz, N Thon, S Eigenbrod, C Hartmann, R Egensperger, J Herms, ... Neuro-oncology 13 (3), 307 , 2011 2011 Citations: 284
[ 18 F]-fluoro-ethyl- l -tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma M Hutterer, M Nowosielski, D Putzer, NL Jansen, M Seiz, M Schocke, ... Neuro-oncology 15 (3), 341-351 , 2013 2013 Citations: 273
Two decades of SPECT/CT–the coming of age of a technology: an updated review of literature evidence O Israel, O Pellet, L Biassoni, D De Palma, E Estrada-Lobato, ... European journal of nuclear medicine and molecular imaging 46 (10), 1990-2012 , 2019 2019 Citations: 264
The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder KH Krause, SH Dresel, J Krause, C la Fougere, M Ackenheil Neuroscience & Biobehavioral Reviews 27 (7), 605-613 , 2003 2003 Citations: 262
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases LA Hoffmann, S Jarius, HL Pellkofer, M Schueller, M Krumbholz, F Koenig, ... Journal of Neurology, Neurosurgery & Psychiatry 79 (7), 767-773 , 2008 2008 Citations: 231
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial U Nestle, T Schimek-Jasch, S Kremp, A Schaefer-Schuler, M Mix, ... The Lancet Oncology 21 (4), 581-592 , 2020 2020 Citations: 230
Imaging and diagnostic advances for intracranial meningiomas RY Huang, WL Bi, B Griffith, TJ Kaufmann, C la Fougère, NO Schmidt, ... Neuro-oncology 21 (Supplement_1), i44-i61 , 2019 2019 Citations: 227
MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? NL Jansen, V Graute, L Armbruster, B Suchorska, J Lutz, S Eigenbrod, ... European journal of nuclear medicine and molecular imaging 39 (6), 1021-1029 , 2012 2012 Citations: 220
Biological tumor volume in 18 FET-PET before radiochemotherapy correlates with survival in GBM B Suchorska, NL Jansen, J Linn, H Kretzschmar, H Janssen, S Eigenbrod, ... Neurology 84 (7), 710-719 , 2015 2015 Citations: 210